Innovating Works

FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA

Activa
ROBOCOOP-EU: circulaR bioecOnomy Business mOdels owned by agroCOOPeratives UNIVERSIDAD DE EXTREMADURA tramitó un HORIZON EUROPE: The bioeconomy roll-out on a large scale needs the establishment of new models and interactions between the primary sector and other stakeholders toward co-participated bioindustries. In this sense, R...
2023-05-22 | Financiado
MARBLES: Marine Biodiversity as Sustainable Resource of Disease-Suppressive Microbes and Bioprotectants for Aquaculture and Crop Diseases UNIVERSITEIT LEIDEN tramitó un H2020: MARBLES will use a novel and systematic approach to access and exploit marine microbial biodiversity for sustainable bioprospecting to discover microbial consortia and bioactive molecules for applicat...
2021-05-01 | Financiado
PTA2021-020827-I: Técnico de apoyo en la plataforma bioanalítica basada en espectrometría de masas de Fundación MEDINA. FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un AEI: 2021-01-01 | Financiado
PID2020-119559RB-I00: MEDINAMICINA, UN NUEVO Y POTENTE INHIBIDOR DE LAS TRANSGLICOSILASAS BACTERIANAS: BIOSINTESIS, OPTIMIZACION DE SU PRODUCCION Y GENERACION DE ANALOGOS CON MEJOR FARMACOLOGIA FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un AEI: LA RESISTENCIA A ANTIMICROBIANOS (AMR) ES UNO DE LOS GRANDES DESAFIOS MUNDIALES EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS, PARA EVITAR LA PROPAGACION DE LAS BACTERIAS RESISTENTES A ANTIMICROBIANOS...
2020-01-01 | Financiado
TOPCAPI: Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients THE UNIVERSITY OF MANCHESTER tramitó un H2020: TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE2270, a starter compound for the semi-synthesis of NAI-Acne, a...
2017-01-01 | Financiado
MarPipe: Improving the flow in the pipeline of the next generation of marine biodiscovery scientists CONSIGLIO NAZIONALE DELLE RICERCHE tramitó un H2020: MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8 countries (I, N, UK, D, B, IRL, E, NL), including 3 from th...
2016-11-01 | Financiado
BLUEandGREEN: Boosting scientific excellence and innovation capacity in biorefineries based on marine resources CENTRO INTERDISCIPLINAR DE INVESTIGACAO MARINHA E AMBIENTAL tramitó un H2020: The exploitation of the ocean unraveled a huge diversity of organisms producing innovative compounds used as pharmaceuticals, nutraceuticals, cosmeceuticals and antifoulings. The aim of BLUEandGREEN i...
2016-01-01 | Financiado
Ocean Medicines: Ocean Medicines CONSIGLIO NAZIONALE DELLE RICERCHE tramitó un H2020: Marine organisms have the capacity to produce a variety of biologically potent natural products. Such novel molecules have new mechanisms of action and therefore could be used to treat human diseases...
2015-12-01 | Financiado
ENABLE: European Gram Negative Antibacterial Engine GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. tramitó un FP6: The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic o...
2014-02-01 | Financiado
PEJ-2014-P-01316: - FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un AEI: 2014-01-01 | Financiado
MICROSMETICS: Exploitation of microbial biodiversity for the discovery and development of novel cosmeceutical agents ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON tramitó un FP7: MICROSMETICS aims to discover and carry to the stage of development innovative products in the area of cosmeceuticals originating from global biodiversity using emerging and state of the art technolog...
2013-11-01 | Financiado
PHARMASEA: Increasing Value and Flow in the Marine Biodiscovery Pipeline KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un FP7: The PharmaSea project focuses on obstacles in marine biodiscovery research, development and commercialization and brings together a broad interdisciplinary team of academic and industry researchers an...
2012-10-01 | Financiado
PARAMET: A systematic analysis of parasite metabolism - from metabolism to intervention UNIVERSITY OF GLASGOW tramitó un FP7: Parasites exact a devastating toll on health and economic productivity, infecting man and also domestic livestock. Drugs used to combat parasitic diseases are deficient in many ways and new, better d...
2012-06-01 | Financiado
DOSYMNPS: Novel applications of diffusion NMR spectroscopy in microbial natural products research FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un FP7: Natural products have inspired chemists by their rich structural diversity and complexity while playing a pivotal role as sources for drug lead compounds during the last century. However, in order for...
2011-09-01 | Financiado
COCULMICRO: Cocultivation of microorganisms as a strategy for discovery of new natural products with antimicrobial properties FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un FP7: New antibiotics are urgently needed to combat persistent, emerging and re-emerging infectious diseases. Historically, microbial natural products have been a prolific source of antibacterials, and the...
2011-08-01 | Financiado
SAF2010-15010: DESCUBRIMIENTO Y CARACTERIZACION DE NUEVOS ANTIBIOTICOS MEDIANTE EL CULTIVO DE BACTERIAS NO CULTIVADAS CON ANTERIORIDAD FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un AEI: HOY EN DIA SE NECESITAN NUEVOS ANTIBIOTICOS PARA COMBATIR ENFERMEDADES INFECCIOSAS PERSISTENTES, EMERGENTES Y RECURRENTES, ASI COMO AQUELLAS CON RESISTENCIAS ADQUIRIDAS EN HOSPITALES, HISTORICAMENTE,...
2010-01-01 | Financiado
FCDE10-1E-221: Biorreactores de Escala Media para la Obtención de Moléculas Bioactivas de Origen Microbiano FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA tramitó un AEI: La Fundación MEDINA emplea microorganismos para obtener moléculas orgánicas de bajo peso molecular, que son después usadas en su plataforma de descubrimiento de nuevos fármacos, Estas moléculas son bi...
2010-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.